The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

University of Munich and Breast Cancer Centre

Bookmark and Share

EBCC 6 2008

15 - 19 Apr 2008

Please rate this video

The information in this video was of interest to me

The information in this video is likely to improve my clinical practice or research

I would recommend this video to my colleagues
Published: 3 Dec 2008
Views: 14368
Rating:
Save
Professor Michael Untch
Prof. Untch discusses his study into combining trastuzumab with neoadjuvant chemotherapy before surgery and surprising new data on safety and efficacy.

Related Videos

SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC
Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
22 Dec 2021
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgr...
Dr Sara Hurvitz - University of California, Los Angeles, USA
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ( Dr Sara Hurvitz - University of California, Los Angeles, USA )
21 Dec 2021
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + tr...
Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease ( Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Dec 2021
The RxPONDER trial and its impact on best clinical practice
Prof Christos Markopoulos and Prof Giuseppe Curigliano
The RxPONDER trial and its impact on best clinical practice ( Prof Christos Markopoulos and Prof Giuseppe Curigliano )
17 Dec 2021
OncoAlert and ecancer weekly round up: SABCS 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up: SABCS 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
16 Dec 2021
Clinical utility of molecular tumour profiling in breast cancer
Prof Fabrice André - Gustave Roussy, Paris, France
Clinical utility of molecular tumour profiling in breast cancer ( Prof Fabrice André - Gustave Roussy, Paris, France )
13 Dec 2021
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Dec 2021
The Lancet Commission on women and cancer
Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg ...
The Lancet Commission on women and cancer ( Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg - International Agency for Research on Cancer, New York, USA )
3 Dec 2021
Breast cancer treatment and ABC global alliance communication skills training wo...
Dr Fatima Cardoso - Champalimaud Clinical Center in Lisbon, Portugal
Breast cancer treatment and ABC global alliance communication skills training workshop ( Dr Fatima Cardoso - Champalimaud Clinical Center in Lisbon, Portugal )
15 Nov 2021

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation